Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus

被引:23
|
作者
Iwabuchi, Atsushi [1 ]
Kamoda, Tomohiro [1 ]
Saito, Makoto [1 ]
Nozue, Hiroki [2 ]
Izumi, Isho [3 ]
Hirano, Takeki [4 ]
Sumazaki, Ryo [1 ]
机构
[1] Univ Tsukuba, Fac Med, Dept Pediat, Tsukuba, Ibaraki 3058575, Japan
[2] Tsukuba Med Ctr Hosp, Dept Pediat, Ibaraki, Japan
[3] Ibaraki Childrens Hosp, Dept Pediat, Ibaraki, Japan
[4] Hirano Childrens Clin, Dept Pediat, Ibaraki, Japan
来源
关键词
adiponectin; CD26; dipeptidyl peptidase 4; type 1 diabetes mellitus; CELL-ACTIVATION ANTIGEN; BODY-MASS INDEX; INSULIN-RESISTANCE; GLYCEMIC CONTROL; YOUNG-PEOPLE; ADIPONECTIN; OBESITY; CD26; ASSOCIATION; SITAGLIPTIN;
D O I
10.1515/jpem-2013-0122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is poorly understood whether dipeptidyl peptidase 4 (DPP4) activity is altered and how DPP4 contributes to glycemic control in patients with type 1 diabetes mellitus (T1DM). Aim: The aim of this study was to measure serum DPP4 activity and to assess its relationships to metabolic variables in T1DM children. Methods: Serum DPP4 activity was determined using a fluorometric assay in 43 T1DM and 26 control children. Results: Serum DPP4 activity was significantly higher in T1DM children than in controls (3.57 +/- 0.99 vs. 2.67 +/- 0.77 U/mL, p<0.001). In the T1DM children, DPP4 activity was not correlated with HbA(1c), blood glucose, or diabetes duration. A significant negative correlation was found between DPP4 activity and serum adiponectin levels in the T1DM group (r=-0.35, p<0.05). Conclusions: Serum DPP4 activity was increased in the T1DM children, whereas it was not associated with glycemic control. Given the negative correlation between serum DPP4 and adiponectin levels, further investigations are warranted to elucidate the role of DPP4 on insulin sensitivity in T1DM children.
引用
收藏
页码:1093 / 1097
页数:5
相关论文
共 50 条
  • [1] Higher serum dipeptidyl peptidase-4 activity in type 1 diabetes mellitus than in type 2: a direct comparison
    Varga, T.
    Somogyi, A.
    Nagy, G.
    Tulassay, Z.
    Selmeci, L.
    Firneisz, G.
    [J]. DIABETOLOGIA, 2008, 51 : S239 - S239
  • [2] Elevation of serum dipeptidyl peptidase-4 activity in type 1 diabetes: Potential explanations and implications
    Firneisz, Gabor
    Zoka, Andras
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 127 : 291 - 292
  • [3] Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
    Carolyn F. Deacon
    [J]. Nature Reviews Endocrinology, 2020, 16 : 642 - 653
  • [4] Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
    Deacon, Carolyn F.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (11) : 642 - 653
  • [5] Serum dipeptidyl peptidase-4 is associated with multiple vertebral fractures in type 2 diabetes mellitus
    Notsu, Masakazu
    Kanazawa, Ippei
    Tanaka, Sayuri
    Yamaguchi, Toru
    Sugimoto, Toshitsugu
    [J]. CLINICAL ENDOCRINOLOGY, 2016, 84 (03) : 332 - 337
  • [6] Significant elevation of serum dipeptidyl peptidase-4 activity in young-adult type 1 diabetes
    Osawa, Saeko
    Kawamori, Dan
    Katakami, Naoto
    Takahara, Mitsuyoshi
    Sakamoto, Fumie
    Katsura, Takashi
    Yasuda, Tetsuyuki
    Kaneto, Hideaki
    Matsuhisa, Munehide
    Matsuoka, Taka-aki
    Shimomura, Iichiro
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 113 : 135 - 142
  • [7] Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes
    Al-Aissa, Zahra
    Rosta, Klara
    Hadarits, Orsolya
    Harreiter, Juergen
    Zoka, Andras
    Bancher-Todesca, Dagmar
    Patocs, Attila
    Kiss, Katalin
    Sarman, Beatrix
    Pusztai, Peter
    Sziller, Istvan
    Rigo, Janos
    Racz, Karoly
    Somogyi, Aniko
    Kautzky-Willer, Alexandra
    Firneisz, Gabor
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2015, 45 (02) : 196 - 203
  • [8] Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
    Neumiller, Joshua J.
    Wood, Lindy
    Campbell, R. Keith
    [J]. PHARMACOTHERAPY, 2010, 30 (05): : 463 - 484
  • [9] Dipeptidyl peptidase 4 expression and activity in rodent models of type 1 and 2 diabetes
    Ikeda, D.
    Sakaue, S.
    Tsujino, I.
    Ohtsuka, Y.
    Nishimura, M.
    [J]. DIABETOLOGIA, 2009, 52 : S315 - S315
  • [10] Emerging Roles of Dipeptidyl Peptidase-4 Inhibitors in Delaying the Progression of Type 1 Diabetes Mellitus
    Penaforte-Saboia, Jaquellyne Gurgel
    Barra Couri, Carlos Eduardo
    Albuquerque, Natasha Vasconcelos
    Lima Silva, Vanessa Lauanna
    da Cunha Olegario, Natalia Bitar
    Fernandes, Virginia Oliveira
    Montenegro Junior, Renan Magalhaes
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 565 - 573